Work

Figure S6 from Targeting Semaphorin 7a Signaling in Preclinical Models of Endocrine Therapy–Resistant Breast Cancer

Year: 2026

Type: other

Abstract: Figure S6 shows in vitro combination treatment with endocrine therapy and SmAbH1 via cell viability and synergy scores, the IC50 and ELISA binding for rSmAbH1, and in vivo mouse weights and blood panel data from the in vivo combination study.

DOI: 10.1158/1535-7163.33414243

Authors: Rachel N. Steinmetz, Veronica Wessells, Heather Fairchild, Virgina F. Borges, Traci R. Lyons

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7204987000

Cites:

Cited by:

Related to: